信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·上海医药2021年报：营收突破2100亿，净利润超50亿2022-3-30 20:23:00
·老中医的春天来了：盘龙药业拿下11天10板葛兰早看上了同仁堂2022-3-30 19:57:43
·德源药业去年净利润7789万元：糖尿病药收入稳增24%高血压药收入大增169%2022-3-30 19:29:17
·原子高科2021年净利2.68亿同比增长20.89%放射性药物收入增长2022-3-30 18:55:22
·吉林敖东：子公司开展生产新冠肺炎防控中药2022-3-30 18:17:18
·京新药业2021年销售费用7.6亿元：占营收23%销售业务费5.2亿元2022-3-30 17:26:04
·林小伟等：价格和医保政策倾斜或加快中药新药研发上市2022-3-30 16:57:17
·复盘90涨停股：中国医药2连板农发种业断板九安医疗尾盘炸板2022-3-30 16:27:56
·中医药行业点评：《“十四五”中医药发展规划》重磅出台利好中医药行业关注中药+中医服务公司2022-3-30 16:19:49
·91只个股涨停主要集中在房地产、医药生物等行业2022-3-30 15:54:14
·民生证券：中医药正式迈入高质量发展阶段行业打开中长期想象空间2022-3-30 15:12:19
·医药生物行业：《“十四五”中医药发展规划》发布行业景气度值得期待2022-3-30 15:00:14
·北陆药业2021年净利润1.25亿元同比下滑28%：市场推广费1.97亿元2022-3-30 14:49:54
·医药生物行业事件点评：合力共同推动中医药振兴发展2022-3-30 14:49:48
·新冠药概念股尾盘再度冲高美诺华反包涨停2022-3-30 14:36:20
·泓德基金邬传雁：看好创新药、职业教育等行业2022-3-30 14:23:59
·北陆药业：2022年继续聚焦重点战略领域并积极布局新赛道2022-3-30 13:50:29
·工银瑞信基金赵蓓：香港生物医药板块进入估值相对合理阶段2022-3-30 13:46:09
·[公司]子公司君元药业通过GMP符合性检查赛升药业产能提升在即2022-3-30 13:42:08
·国药一致2021年净利13.36亿同比下滑4.67%总经理林兆雄薪酬250万2022-3-30 13:38:31

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]